Rage Ciwon Bayan-Aiki tare da amfani da CBD

Kwamfutar da aka sha da baki da ke dauke da cannabidiol (CBD) da kyau yana rage jin zafi bayan tiyatar kafada ba tare da damuwa da aminci ba, sabon binciken ya gano.      

Jagoran masu bincike a cikin Ma'aikatar Orthopedic Surgery a NYU Langone Health, binciken ya gano cewa kwamfutar hannu ORAVEXX a amince da jin zafi bayan tiyatar rotator cuff kadan, kuma bai haifar da sakamako masu illa a wasu lokuta hade da amfani da CBD ba, kamar tashin zuciya, damuwa, da tashin hankali. yawan hanta. An gabatar da binciken a Cibiyar Nazarin Orthopedic Surgeon ta Amurka (AAOS) 2022 Taron Shekara-shekara a Chicago.

"Akwai buƙatar gaggawa don hanyoyin da za a iya amfani da su don kula da ciwo, kuma bincikenmu ya gabatar da wannan nau'i na CBD a matsayin kayan aiki mai ban sha'awa bayan gyaran gyare-gyare na arthroscopic," in ji mai binciken jagoran Michael J. Alaia, MD, FAAOS, masanin farfesa a Sashen Tiyatar Orthopedic. "Yana iya zama sabuwar hanya, mara tsada don isar da taimako na jin zafi, kuma ba tare da illar magungunan ƙwayoyin cuta kamar NSAIDs da haɗarin jaraba da ke da alaƙa da opiates ba. Bugu da ƙari, CBD yana da fa'idar rage jin zafi ba tare da tasirin psychotropic da ke da alaƙa da THC ko marijuana ba. ”

Tsarin gwaji na asibiti na multicenter 1/2 ya rarraba mahalarta 99 bazuwar a cikin wuraren binciken 2 (NYU Langone Health and Baptist Health/Jacksonville Orthopedic Institute) tsakanin shekarun 18 da 75 a cikin rukunin placebo da ƙungiyar da ke karɓar CBD ta baka. An wajabta wa mahalarta ƙaramin kashi na Percocet, an umurce su da su cire narcotic da wuri-wuri, kuma su ɗauki placebo / CBD sau 3 a rana don kwanaki 14 bayan tiyata. 

A rana ta farko bayan tiyata, marasa lafiya da ke karɓar CBD sun samu a matsakaicin 23 bisa dari ƙasa da zafi kamar yadda aka auna ta hanyar ma'aunin zafi na gani na gani (VAS) idan aka kwatanta da marasa lafiya da ke karɓar placebo, yana nuna cewa a cikin marasa lafiya da matsakaicin zafi, CBD na iya ba da babbar fa'ida. . A duka kwanaki na farko da na biyu bayan tiyata, marasa lafiya da ke karɓar CBD sun ruwaito 22 zuwa 25 bisa dari mafi girma gamsuwa tare da kula da ciwo idan aka kwatanta da waɗanda ke karɓar placebo. Ƙarin bincike kuma ya nuna cewa marasa lafiya da ke karɓar 50 MG na CBD sun ba da rahoton ƙananan ciwo da kuma gamsuwa mafi girma tare da kula da ciwo idan aka kwatanta da marasa lafiya da ke karbar placebo. Ba a sami rahoton wani babban illa ba.

Duk da yake sakamakon yana da alƙawarin, Dokta Alaia ya gargaɗi masu amfani da su game da neman samfuran CBD na kasuwanci. "Bincikenmu yana nazarin ingantaccen tsari, samfurin da aka bincika a hankali a ƙarƙashin sabon binciken da FDA ta amince da shi. Wannan a halin yanzu har yanzu maganin gwaji ne kuma har yanzu ba a samu don rubuta magani ba, ”in ji shi.

ORAVEXX, kwamfutar hannu da aka yi amfani da ita a cikin wannan binciken, Orcosa Inc., kamfanin kimiyyar rayuwa ne ya ƙera shi kuma ya kera shi. Abu ne mai ban sha'awa, mai saurin shayarwa na CBD wanda aka tsara don magance ciwo.

Ci gaba, NYU Langone ya kaddamar da bincike na biyu yana kallon ko ORAVEXX zai iya magance ciwo mai tsanani a cikin marasa lafiya tare da osteoarthritis. Hakanan an tsara nazarin karatun 2 da yawa don kimanta tasirin miyagun ƙwayoyi don wasu batutuwan kula da ciwo mai tsanani da na yau da kullun da kuma tantance rawar CBD akan kumburi.